Drug Safety Alerts
Attention (ALERT)!
Tablet: BLACK COBRA 125
Description: Red coloured trigonal tablets, engraved 125 on one side, packed in a blister.
Batch No. CBT 117
Mfg. Date: Jan 2017
Exp. Date: December 2020
Manufactured by: Combitic Global D-2 Industrial Area India.
Background: Provincial Drug Inspector collected the sample from Boson Town, Multan and sent it to the Punjab Drug Testing Laboratory (DTL) for testing and analysis.
Problem: DTL found Allopathic Ingredient “Sildenafil Citrate” in this preparation. Sildenafil Citrate is a Vasodilator and may have severe adverse effect in specific population. Therefore, DTL has declared it SUB-STANDARD!
Recommendation: This product does not meet appropriate quality standards and specifications and may therefore, be ineffective and potentially harmful to patients. All concerned are intimated to keep caution in procurement, dispensation, promotion and use of this pharmaceutical product.
Note. Healthcare professionals and consumers are encouraged to report adverse events or side effects related to the use of any pharmaceutical product to Provincial Drugs Control Unit Punjab through mentioned URL: mss.punjab.gov.pk/reporttgrp
Primary & Secondary Healthcare Department,
Govt. of the Punjab